Differential Regulation of $\beta $1 and $\beta $2 Integrin Avidity by Chemoattractants in Eosinophils

The CC chemokines regulated on activation normal T expressed and secreted (RANTES) and monocyte chemotactic protein 3 (MCP-3), and the anaphylatoxin C5a, induce activation, degranulation, chemotaxis, and transendothelial migration of eosinophils. Adhesion assays on purified ligands showed differenti...

Full description

Saved in:
Bibliographic Details
Published inProceedings of the National Academy of Sciences - PNAS Vol. 93; no. 20; pp. 10939 - 10944
Main Authors Weber, Christian, Kitayama, Joji, Springer, Timothy A.
Format Journal Article
LanguageEnglish
Published United States National Academy of Sciences of the United States of America 01.10.1996
National Acad Sciences
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The CC chemokines regulated on activation normal T expressed and secreted (RANTES) and monocyte chemotactic protein 3 (MCP-3), and the anaphylatoxin C5a, induce activation, degranulation, chemotaxis, and transendothelial migration of eosinophils. Adhesion assays on purified ligands showed differential regulation of $\beta $1 and $\beta $2 integrin avidity in eosinophils. Adhesiveness of VLA-4 ($\alpha $4$\beta $1, CD29/CD49d) for vascular cell adhesion molecule 1 or fibronectin was rapidly increased but subsequently reduced by RANTES, MCP-3, or C5a. The deactivation of VLA-4 lead to cell detachment, whereas phorbol 12-myristate 13-acetate induced sustained activation of VLA-4. In contrast, chemoattractants stimulated a prolonged increase in the adhesiveness of Mac-1 ($\alpha $M$\beta $2, CD11b/CD18) for intercellular adhesion molecule 1. Inhibition by pertussis toxin confirmed signaling via G protein-coupled receptors. Chemoattractants induced transient, while phorbol 12-myristate 13-acetate induced sustained actin polymerization. Disruption of actin filaments by cytochalasins inhibited increases in avidity of VLA-4 but not of Mac-1. Chemoattractants did not upregulate a Mn$^{2+}$-inducible $\beta $1 neoepitope defined by the mAb 9EG7, but induced prolonged expression of a Mac-1 activation epitope recognized by the mAb CBRM1/5. This mAb inhibited chemoattractant-stimulated adhesion of eosinophils to intercellular adhesion molecule 1. Thus, regulation of VLA-4 was dependent on the actin cytoskeleton, whereas conformational changes appeared to be crucial for activation of Mac-1. To our knowledge, this is the first demonstration that physiological agonists, such as chemoattractants, can differentially regulate the avidity of a $\beta $1 and a $\beta $2 integrin expressed on the same leukocyte.
AbstractList The CC chemokines regulated on activation normal T expressed and secreted (RANTES) and monocyte chemotactic protein 3 (MCP-3), and the anaphylatoxin C5a, induce activation, degranulation, chemotaxis, and transendothelial migration of eosinophils. Adhesion assays on purified ligands showed differential regulation of beta 1 and beta 2 integrin avidity in eosinophils. Adhesiveness of VLA-4 (alpha 4 beta 1, CD29/CD49d) for vascular cell adhesion molecule 1 or fibronectin was rapidly increased but subsequently reduced by RANTES, MCP-3, or C5a. The deactivation of VLA-4 lead to cell detachment, whereas phorbol 12-myristate 13-acetate induced sustained activation of VLA-4. In contrast, chemoattractants stimulated a prolonged increase in the adhesiveness of Mac-1 (alpha M beta 2, CD11b/CD18) for intercellular adhesion molecule 1. Inhibition by pertussis toxin confirmed signaling via G protein-coupled receptors. Chemoattractants induced transient, while phorbol 12-myristate 13-acetate induced sustained actin polymerization. Disruption of actin filaments by cytochalasins inhibited increases in avidity of VLA-4 but not of Mac-1. Chemoattractants did not upregulate a Mn2+-inducible beta 1 neoepitope defined by the mAb 9EG7, but induced prolonged expression of a Mac-1 activation epitope recognized by the mAb CBRM1/5. This mAb inhibited chemoattractant-stimulated adhesion of eosinophils to intercellular adhesion molecule 1. Thus, regulation of VLA-4 was dependent on the actin cytoskeleton, whereas conformational changes appeared to be crucial for activation of Mac-1. To our knowledge, this is the first demonstration that physiological agonists, such as chemoattractants, can differentially regulate the avidity of a beta 1 and a beta 2 integrin expressed on the same leukocyte.
The CC chemokines regulated on activation normal T expressed and secreted (RANTES) and monocyte chemotactic protein 3 (MCP-3), and the anaphylatoxin C5a, induce activation, degranulation, chemotaxis, and transendothelial migration of eosinophils. Adhesion assays on purified ligands showed differential regulation of beta 1 and beta 2 integrin avidity in eosinophils. Adhesiveness of VLA-4 ( alpha 4 beta 1, CD29/CD49d) for vascular cell adhesion molecule 1 or fibronectin was rapidly increased but subsequently reduced by RANTES, MCP-3, or C5a. The deactivation of VLA-4 lead to cell detachment, whereas phorbol 12-myristate 13-acetate induced sustained activation of VLA-4. In contrast, chemoattractants stimulated a prolonged increase in the adhesiveness of Mac-1 ( alpha M beta 2, CD11b/CD18) for intercellular adhesion molecule 1. Inhibition by pertussis toxin confirmed signaling via G protein-coupled receptors. Chemoattractants induced transient, while phorbol 12-myristate 13-acetate induced sustained actin polymerization. Disruption of actin filaments by cytochalasins inhibited increases in avidity of VLA-4 but not of Mac-1. Chemoattractants did not upregulate a Mn super(2+)-inducible beta 1 neoepitope defined by the mAb 9EG7, but induced prolonged expression of a Mac-1 activation epitope recognized by the mAb CBRM1/5. This mAb inhibited chemoattractant-stimulated adhesion of eosinophils to intercellular adhesion molecule 1. Thus, regulation of VLA-4 was dependent on the actin cytoskeleton, whereas conformational changes appeared to be crucial for activation of Mac-1. To our knowledge, this is the first demonstration that physiological agonists, such as chemoattractants, can differentially regulate the avidity of a beta 1 and a beta 2 integrin expressed on the same leukocyte.
The CC chemokines regulated on activation normal T expressed and secreted (RANTES) and monocyte chemotactic protein 3 (MCP-3), and the anaphylatoxin C5a, induce activation, degranulation, chemotaxis, and transendothelial migration of eosinophils. Adhesion assays on purified ligands showed differential regulation of $\beta $1 and $\beta $2 integrin avidity in eosinophils. Adhesiveness of VLA-4 ($\alpha $4$\beta $1, CD29/CD49d) for vascular cell adhesion molecule 1 or fibronectin was rapidly increased but subsequently reduced by RANTES, MCP-3, or C5a. The deactivation of VLA-4 lead to cell detachment, whereas phorbol 12-myristate 13-acetate induced sustained activation of VLA-4. In contrast, chemoattractants stimulated a prolonged increase in the adhesiveness of Mac-1 ($\alpha $M$\beta $2, CD11b/CD18) for intercellular adhesion molecule 1. Inhibition by pertussis toxin confirmed signaling via G protein-coupled receptors. Chemoattractants induced transient, while phorbol 12-myristate 13-acetate induced sustained actin polymerization. Disruption of actin filaments by cytochalasins inhibited increases in avidity of VLA-4 but not of Mac-1. Chemoattractants did not upregulate a Mn$^{2+}$-inducible $\beta $1 neoepitope defined by the mAb 9EG7, but induced prolonged expression of a Mac-1 activation epitope recognized by the mAb CBRM1/5. This mAb inhibited chemoattractant-stimulated adhesion of eosinophils to intercellular adhesion molecule 1. Thus, regulation of VLA-4 was dependent on the actin cytoskeleton, whereas conformational changes appeared to be crucial for activation of Mac-1. To our knowledge, this is the first demonstration that physiological agonists, such as chemoattractants, can differentially regulate the avidity of a $\beta $1 and a $\beta $2 integrin expressed on the same leukocyte.
Author Weber, Christian
Kitayama, Joji
Springer, Timothy A.
AuthorAffiliation Center for Blood Research, Harvard Medical School, Boston, MA 02115, USA
AuthorAffiliation_xml – name: Center for Blood Research, Harvard Medical School, Boston, MA 02115, USA
Author_xml – sequence: 1
  givenname: Christian
  surname: Weber
  fullname: Weber, Christian
– sequence: 2
  givenname: Joji
  surname: Kitayama
  fullname: Kitayama, Joji
– sequence: 3
  givenname: Timothy A.
  surname: Springer
  fullname: Springer, Timothy A.
BackLink https://www.ncbi.nlm.nih.gov/pubmed/8855287$$D View this record in MEDLINE/PubMed
BookMark eNqFkc1rGzEQxUVJSZ2091Io1SGEXNbVx65WC70EN0kDgUBpbwUhrSRbYS05kjbU_3212DXppTkNw_u9YR7vBBz54A0A7zGaY9TSzxsv07yjczLtHe1egVmZuGJ1h47ADCHSVrwm9RtwktIDQqhrODoGx5w3DeHtDNivzloTjc9ODvC7WY6DzC54GCw8-6VMlvAMQ-n1YSPw1mezjM7DyyenXd5CtYWLlVkHmXOUfZY-J1jkq5CcD5uVG9Jb8NrKIZl3-3kKfl5f_Vh8q-7ub24Xl3dVX3d1riRDppbSatSQvrEMYa5LHosURdgqxXrTWkKKqHCLW62ssrU0THPNlNYNPQVfdnc3o1ob3ZdcUQ5iE91axq0I0ol_Fe9WYhmeBOWEkWI_39tjeBxNymLtUm-GQXoTxiRaXmPWEfYiiBveYEpwAdEO7GNIKRp7-AUjMVUopgpFRwWZ9lJhsXx8nuFg2HdW9Iu9Pjn_qs8uCDsOQza_c0E__R8txIcd8ZByiAekRoRh-geXdLzH
CitedBy_id crossref_primary_10_1016_S1074_7613_00_00074_1
crossref_primary_10_1186_s13075_015_0664_8
crossref_primary_10_4049_jimmunol_160_11_5622
crossref_primary_10_1007_s00441_004_0925_3
crossref_primary_10_1091_mbc_12_7_2137
crossref_primary_10_1182_blood_V96_2_506_014k41_506_513
crossref_primary_10_1189_jlb_0104054
crossref_primary_10_1007_s11882_004_0061_x
crossref_primary_10_1091_mbc_10_4_861
crossref_primary_10_1159_000053588
crossref_primary_10_1016_S0022_1759_00_00192_7
crossref_primary_10_1165_rcmb_2004_0099OC
crossref_primary_10_1046_j_1365_2141_1999_01714_x
crossref_primary_10_1096_fj_04_3085fje
crossref_primary_10_4049_jimmunol_160_10_4889
crossref_primary_10_1002_1521_4141_200204_32_4_1069__AID_IMMU1069_3_0_CO_2_E
crossref_primary_10_1046_j_1365_2567_1999_00766_x
crossref_primary_10_1084_jem_193_10_1149
crossref_primary_10_1067_mai_2000_110797
crossref_primary_10_1074_jbc_M907390199
crossref_primary_10_1182_blood_V95_2_592
crossref_primary_10_1182_blood_V96_2_506
crossref_primary_10_1074_jbc_M212538200
crossref_primary_10_1002_art_30582
crossref_primary_10_1189_jlb_0707478
crossref_primary_10_1074_jbc_M210472200
crossref_primary_10_1111_j_1365_2567_2008_02906_x
crossref_primary_10_1165_rcmb_2006_0027OC
crossref_primary_10_1016_S1081_1206_10_61311_7
crossref_primary_10_1159_000053592
crossref_primary_10_1074_jbc_273_17_10556
crossref_primary_10_1189_jlb_0607344
crossref_primary_10_1155_2015_301716
crossref_primary_10_4049_jimmunol_161_2_971
crossref_primary_10_1189_jlb_1105643
crossref_primary_10_4049_jimmunol_169_5_2670
crossref_primary_10_1034_j_1600_065X_2002_18604_x
crossref_primary_10_1242_jcs_02632
crossref_primary_10_1189_jlb_71_5_798
crossref_primary_10_1189_jlb_71_3_520
crossref_primary_10_1124_mol_105_018374
crossref_primary_10_1165_ajrcmb_20_6_3531
crossref_primary_10_1074_jbc_M206208200
crossref_primary_10_1161_01_ATV_0000200226_53994_09
crossref_primary_10_4049_jimmunol_164_6_3292
crossref_primary_10_1189_jlb_72_5_1046
crossref_primary_10_1016_S0091_6749_97_70027_7
crossref_primary_10_4049_jimmunol_168_3_1380
crossref_primary_10_1096_fj_02_0739rev
crossref_primary_10_1006_smim_2001_0346
crossref_primary_10_1006_smim_2001_0345
crossref_primary_10_1016_S0955_0674_02_00371_X
crossref_primary_10_1182_blood_2007_05_093294
crossref_primary_10_1189_jlb_0605318
crossref_primary_10_1038_sj_mn_7800195
crossref_primary_10_1016_S0166_2236_98_01390_3
crossref_primary_10_1046_j_1365_2567_2002_01486_x
crossref_primary_10_1111_j_1365_2567_2005_02214_x
crossref_primary_10_1016_j_intimp_2007_07_006
crossref_primary_10_1111_j_1750_3639_2007_00067_x
crossref_primary_10_1016_j_it_2003_08_001
crossref_primary_10_1189_jlb_68_5_679
crossref_primary_10_1007_s11882_002_0005_2
crossref_primary_10_1038_ni755
crossref_primary_10_1016_S0022_1759_99_00052_6
crossref_primary_10_1002__SICI_1521_4141_199807_28_07_2245__AID_IMMU2245_3_0_CO_2_V
crossref_primary_10_4049_jimmunol_166_1_588
crossref_primary_10_1002_1521_4141_200204_32_4_1129__AID_IMMU1129_3_0_CO_2_G
crossref_primary_10_1080_15419060390262507
crossref_primary_10_1152_ajpheart_00349_2002
crossref_primary_10_1165_rcmb_2006_0391OC
crossref_primary_10_1111_cea_12292
crossref_primary_10_1074_jbc_M402944200
crossref_primary_10_1083_jcb_142_2_595
crossref_primary_10_1006_cimm_1999_1596
crossref_primary_10_3390_cancers16030559
crossref_primary_10_1038_sj_bjp_0701243
crossref_primary_10_1083_jcb_137_6_1433
crossref_primary_10_1093_rheumatology_kei207
crossref_primary_10_3390_biomedicines12010124
crossref_primary_10_1091_mbc_12_10_3074
crossref_primary_10_4049_jimmunol_161_12_6825
crossref_primary_10_1016_S0955_0674_97_80127_5
crossref_primary_10_1159_000059412
crossref_primary_10_1006_pupt_2000_0250
crossref_primary_10_1111_j_1600_065X_2012_01127_x
crossref_primary_10_1159_000059414
crossref_primary_10_4049_jimmunol_1401889
crossref_primary_10_1016_S0955_0674_00_00253_2
crossref_primary_10_1016_S0162_3109_99_00178_2
crossref_primary_10_1056_NEJM199805283382206
crossref_primary_10_1074_jbc_M600943200
crossref_primary_10_1046_j_1365_2567_2000_00123_x
crossref_primary_10_4049_jimmunol_163_6_3423
crossref_primary_10_4049_jimmunol_164_2_746
crossref_primary_10_4161_cam_4_1_10976
crossref_primary_10_1016_j_iac_2007_07_004
crossref_primary_10_1046_j_1440_1711_2001_01004_x
crossref_primary_10_1186_s12967_021_02822_5
crossref_primary_10_4049_jimmunol_160_7_3569
crossref_primary_10_1016_S0091_6749_99_70281_2
crossref_primary_10_4049_jimmunol_165_5_2748
crossref_primary_10_4049_jimmunol_167_11_6171
crossref_primary_10_1093_intimm_11_1_1
crossref_primary_10_1165_ajrcmb_19_3_3179
crossref_primary_10_1590_S0074_02761997000800021
crossref_primary_10_4049_jimmunol_164_8_4313
crossref_primary_10_4049_jimmunol_162_2_1084
crossref_primary_10_1016_S0091_6749_97_70158_1
crossref_primary_10_1016_j_cyto_2010_02_016
crossref_primary_10_4049_jimmunol_161_11_5978
crossref_primary_10_4049_jimmunol_1900914
crossref_primary_10_1084_jem_186_2_313
crossref_primary_10_4049_jimmunol_1901134
crossref_primary_10_1159_000053844
crossref_primary_10_1152_ajplung_00437_2001
crossref_primary_10_1097_00003246_200004001_00003
crossref_primary_10_4049_jimmunol_175_9_6092
crossref_primary_10_1067_mai_2000_110813
crossref_primary_10_1006_clim_1999_4829
crossref_primary_10_1016_S0006_3495_04_74196_X
crossref_primary_10_1046_j_1365_2222_2000_00779_x
crossref_primary_10_1007_s10719_008_9215_8
crossref_primary_10_1074_jbc_273_24_15271
crossref_primary_10_1111_j_1365_2222_2007_00117_x
crossref_primary_10_1067_mai_2003_1515
crossref_primary_10_1007_s00223_006_0115_2
crossref_primary_10_1016_S0301_472X_00_00668_8
crossref_primary_10_1067_mai_2001_118600
crossref_primary_10_1016_S0955_0674_97_80117_2
crossref_primary_10_1046_j_1365_2249_2000_01249_x
crossref_primary_10_1002__SICI_1521_4141_199911_29_11_3571__AID_IMMU3571_3_0_CO_2_V
crossref_primary_10_1080_10408369991239277
crossref_primary_10_4049_jimmunol_166_5_3515
crossref_primary_10_1074_jbc_M700341200
crossref_primary_10_1080_10739680600776062
crossref_primary_10_1007_s00005_013_0221_6
crossref_primary_10_1084_jem_192_4_495
crossref_primary_10_1111_cen3_12229
crossref_primary_10_1182_blood_V95_5_1804_005k11_1804_1809
crossref_primary_10_1165_rcmb_2008_0047OC
crossref_primary_10_4049_jimmunol_163_3_1611
crossref_primary_10_4049_jimmunol_166_9_5755
crossref_primary_10_1074_jbc_M103194200
crossref_primary_10_4049_jimmunol_175_8_5341
crossref_primary_10_1189_jlb_0502264
crossref_primary_10_1002_1521_4141_200108_31_8_2458__AID_IMMU2458_3_0_CO_2_L
ContentType Journal Article
Copyright Copyright 1996 National Academy of Sciences
Copyright_xml – notice: Copyright 1996 National Academy of Sciences
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7T5
H94
7X8
5PM
DOI 10.1073/pnas.93.20.10939
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
Immunology Abstracts
AIDS and Cancer Research Abstracts
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
AIDS and Cancer Research Abstracts
Immunology Abstracts
MEDLINE - Academic
DatabaseTitleList
AIDS and Cancer Research Abstracts

CrossRef
MEDLINE - Academic
MEDLINE

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Sciences (General)
EISSN 1091-6490
EndPage 10944
ExternalDocumentID 10_1073_pnas_93_20_10939
8855287
93_20_10939
40261
Genre Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, P.H.S
Journal Article
GrantInformation_xml – fundername: NCI NIH HHS
  grantid: CA31799
GroupedDBID ---
-DZ
-~X
.55
.GJ
0R~
123
29P
2AX
2FS
2WC
3O-
4.4
53G
5RE
5VS
79B
85S
AACGO
AAFWJ
AANCE
ABBHK
ABOCM
ABPLY
ABPPZ
ABTLG
ABXSQ
ABZEH
ACGOD
ACIWK
ACKIV
ACNCT
ACPRK
ADULT
ADZLD
AENEX
AEUPB
AEXZC
AFDAS
AFFNX
AFOSN
AFRAH
ALMA_UNASSIGNED_HOLDINGS
AQVQM
ASUFR
AS~
CS3
D0L
DCCCD
DIK
DNJUQ
DOOOF
DU5
DWIUU
E3Z
EBS
EJD
F20
F5P
FRP
GX1
HGD
HH5
HQ3
HTVGU
HYE
JAAYA
JBMMH
JENOY
JHFFW
JKQEH
JLS
JLXEF
JPM
JSG
JSODD
JST
KQ8
L7B
LU7
MVM
N9A
NEJ
NHB
N~3
O9-
OK1
P-O
PNE
PQQKQ
R.V
RHF
RHI
RNA
RNS
RPM
RXW
SA0
SJN
TAE
TN5
UKR
VOH
VQA
W8F
WH7
WHG
WOQ
WOW
X7M
XFK
XSW
Y6R
YKV
YSK
ZA5
ZCA
ZCG
~02
~KM
-
02
08R
0R
1AW
55
AAPBV
ABFLS
ABPTK
ADACO
AJYGW
AS
DZ
GJ
KM
OHM
PQEST
X
XHC
ADACV
CGR
CUY
CVF
ECM
EIF
H13
IPSME
NPM
692
6TJ
AAYJJ
AAYXX
BKOMP
CITATION
YBH
7T5
H94
7X8
5PM
ID FETCH-LOGICAL-c494t-a60e4aafd052c5f6018d109f0b301fbb6ce7f2252cb1717dbfbf4ae6d8d6bdd53
IEDL.DBID RPM
ISSN 0027-8424
IngestDate Tue Sep 17 21:17:24 EDT 2024
Sat Oct 26 00:21:40 EDT 2024
Fri Oct 25 21:54:31 EDT 2024
Fri Aug 23 03:33:49 EDT 2024
Sat Sep 28 08:34:39 EDT 2024
Wed Nov 11 00:29:44 EST 2020
Wed May 29 08:07:22 EDT 2019
Fri Feb 02 07:05:47 EST 2024
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 20
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c494t-a60e4aafd052c5f6018d109f0b301fbb6ce7f2252cb1717dbfbf4ae6d8d6bdd53
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
OpenAccessLink https://europepmc.org/articles/pmc38262?pdf=render
PMID 8855287
PQID 15851321
PQPubID 23462
PageCount 6
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_38262
proquest_miscellaneous_15851321
crossref_primary_10_1073_pnas_93_20_10939
jstor_primary_40261
pnas_primary_93_20_10939_fulltext
proquest_miscellaneous_78416926
pubmed_primary_8855287
pnas_primary_93_20_10939
ProviderPackageCode RNA
PNE
PublicationCentury 1900
PublicationDate 19961001
1996-10-01
1996-Oct-01
1996-10-00
PublicationDateYYYYMMDD 1996-10-01
PublicationDate_xml – month: 10
  year: 1996
  text: 19961001
  day: 01
PublicationDecade 1990
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Proceedings of the National Academy of Sciences - PNAS
PublicationTitleAlternate Proc Natl Acad Sci U S A
PublicationYear 1996
Publisher National Academy of Sciences of the United States of America
National Acad Sciences
Publisher_xml – name: National Academy of Sciences of the United States of America
– name: National Acad Sciences
SSID ssj0009580
Score 1.9934286
Snippet The CC chemokines regulated on activation normal T expressed and secreted (RANTES) and monocyte chemotactic protein 3 (MCP-3), and the anaphylatoxin C5a,...
SourceID pubmedcentral
proquest
crossref
pubmed
pnas
jstor
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 10939
SubjectTerms Actins
CD18 Antigens - physiology
Cell Adhesion
Chemokine CCL5 - metabolism
Chemokine CCL7
Chemotactic factors
Chemotactic Factors - physiology
Chemotaxis, Leukocyte
Complement C5a - metabolism
Cytokines
Endothelium
Eosinophils
Eosinophils - physiology
Epitopes
Fibronectins - metabolism
Fibrosis
Humans
Integrin alpha4beta1
Integrin beta1 - physiology
Integrins
Integrins - physiology
Isotypes
Ligands
Macrophage-1 Antigen - physiology
Monocyte Chemoattractant Proteins - metabolism
Physiological regulation
Receptors, Lymphocyte Homing - physiology
Vascular Cell Adhesion Molecule-1 - metabolism
Title Differential Regulation of $\beta $1 and $\beta $2 Integrin Avidity by Chemoattractants in Eosinophils
URI https://www.jstor.org/stable/40261
http://www.pnas.org/content/93/20/10939.abstract
https://www.ncbi.nlm.nih.gov/pubmed/8855287
https://search.proquest.com/docview/15851321
https://search.proquest.com/docview/78416926
https://pubmed.ncbi.nlm.nih.gov/PMC38262
Volume 93
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9wwEB6aQCGX0qQNcZqHCj00B-_asvw6lrQhSUnpoYHcXD2JYVdeYufQf9-RLC_Z0lxyM9IIm3lYM8ynTwCfZCoxKUhUjMlwEjOd6rhivIx5omWZas2kpxS6-VFc3rLru_wunOPuA6zSStHO7GI5s-29x1aulnI-4cTmP2_OM8yJ6XwLttA9pwJ9zbNbjadOKP58GWWhM4mOPF9Z3s_qDGtCz6FU78Drqspz6tB0T_akEZbouE5R_n9557_wySf70cVbeBMSSfJl_OBdeKXtHuyGUO3J58AnffYOfn8Nl6BgMC_Iw3j5PJqDdIYIPXCSEm7V-EjJyB_RWuLA7piiE_GHoGGXHR8Gd6LK4WZQiOiub223um8X_Xu4vfj26_wyDhcrxJLVbIh5kWjGuVFJTmVusCarFKrEJALD3QhRSF0aDHQqRYrlnhJGGMZ1oSpVCKXybB-2bWf1ARDN0tJkWJ4LzRlNlKgcnwsTBeWsNiyL4GxSbbMa-TMa3_cus8YpuKmzhvo-eFZHsOd1vxZkrkCM4MALToMbCz4-N9WYgJ2J4HSyYIOR49oh3OrusW9S1xHNaPq8hO_J1rSIYH-0-PpNwXEiyDdcYT3vSLs3Z9CXPXm3993DF677ADseNe7BhEewPTw86mNMigZxguXA1fcTHwx_AQD4Dqw
link.rule.ids 230,315,730,783,787,888,27936,27937,53804,53806
linkProvider National Library of Medicine
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB5BEaKXihaqBgo1Egd6yG7iOK8jKlQLdCsOrdRb8FONtOusmvTAv2fseFddRC_cInusRPOIZzSfPwN8lKnEpCBRMSbDScx0quOK8TLmiZZlqjWTnlJoflnMrtn3m_wmnOPuA6zSStFO7GI5se2tx1aulnK6xolNf87PMsyJ6fQpPMNoTdi6RN8w7VbjuROKv19GWehNoitPV5b3kzrDqtCzKNW78Lyq8pw6PN2DXWkEJjq2U5T_V-b5N4DywY50_hL2QipJPo-fvA9PtD2A_RCsPfkUGKVPX8GvL-EaFAznBbkbr59Hg5DOEKEHTlLCrRofKRkZJFpLHNwdk3QifhM07bLjw-DOVDnkDAoR3fWt7Va37aJ_DdfnX6_OZnG4WiGWrGZDzItEM86NSnIqc4NVWaVQJSYRGPBGiELq0mCoUylSLPiUMMIwrgtVqUIolWeHsGM7q4-AaJaWJsMCXWjOaKJE5RhdmCgoZ7VhWQSna9U2q5FBo_Gd7zJrnIKbOmuo74RndQQHXvcbQeZKxAiOvOB6cGvBh8emGhPQMxGcrC3YYOy4hgi3urvvm9T1RDOaPi7hu7I1LSI4HC2-eVNwnAjyLVfYzDva7u0Z9GZP3-29981_rjuBF7Or-UVz8e3yx1vY9RhyDy08hp3h7l6_wxRpEO99SPwB_aoRCQ
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB5BEagXRAtVw6tG4kAP2SSO8zqillV5tOqBSr0FP9VIu07UpAf-PWMnWXURvXCL4rESzSOeyXz-DPBRJhKTgliFmAzHIdOJDkvGi5DHWhaJ1kx6SqHzi_zsin27zq6nXxf9BKu0UjQLu1ovbHPjsZXdWkYzTiy6PD9JMSemUadM9BieYMTG-Vymb9h2y3HvCcVPMKNs6k-iO0ed5f2iSrEy9ExK1S48Lcssow5Td29lGsGJjvEU5f-Vff4Nory3Ki1fwPMpnSSfx9feg0fa7sPeFLA9-TSxSh-_hF-n01EoGNIrcjseQY9GIa0hQg-cJIRbNV5SMrJINJY4yDsm6kT8JmjedcuHwe2rcugZFCK67RvbdjfNqn8FV8svP0_Owul4hVCyig0hz2PNODcqzqjMDFZmpUKVmFhg0BshcqkLg-FOpUiw6FPCCMO4zlWpcqFUlh7Ajm2tPgSiWVKYFIt0oTmjsRKlY3VhIqecVYalARzPqq27kUWj9t3vIq2dgusqranvhqdVAPte9xtB5srEAA694Hxza8KHh4ZqMyFoAjiaLVhj_LimCLe6vevrxPVFU5o8LOE7sxXNAzgYLb550uQ4AWRbrrAZd9Td2yPo0Z7C23vw6_-cdwTPLk-X9Y-vF9_fwK6HkXt04VvYGW7v9DvMkgbx3kfEH-AAEhw
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Differential+regulation+of+beta+1+and+beta+2+integrin+avidity+by+chemoattractants+in+eosinophils&rft.jtitle=Proceedings+of+the+National+Academy+of+Sciences+-+PNAS&rft.au=Weber%2C+C&rft.au=Kitayama%2C+J&rft.au=Springer%2C+T+A&rft.date=1996-10-01&rft.issn=0027-8424&rft.volume=93&rft.issue=20&rft.spage=10939&rft_id=info:doi/10.1073%2Fpnas.93.20.10939&rft_id=info%3Apmid%2F8855287&rft.externalDocID=8855287
thumbnail_m http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fwww.pnas.org%2Fcontent%2F93%2F20.cover.gif
thumbnail_s http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fwww.pnas.org%2Fcontent%2F93%2F20.cover.gif